Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

imiquimod 50 MG/ML Topical Cream

Known as: imiquimod 50 mg in 1000 mg TOPICAL CREAM [Imiquimod], IMIQUIMOD 12.5 mg in 0.25 g TOPICAL CREAM, IMIQUIMOD 5% TOP CREAM PKT 0.25GM 
 
National Institutes of Health

Related topics

Related topics

19 relations
Benzyl AlcoholCondylomata AcuminataDrug AllergyGlycerin
Expand

Narrower (1)

imiquimod 50 MG/ML Topical Cream [Aldara]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Electrospun Poly(ε-caprolactone) Nanofibrous Mesh for Imiquimod Delivery in Melanoma Therapy
Drug delivery systems (DDS) are commonly employed to administer drug-loaded composites to their therapeutic targets both in vitro… Expand
  • table 1
  • table 2
  • figure 3
  • figure 4
  • figure 6
2017
2017
Development and Characterisation of the Imiquimod Poly(2-(2-methoxyethoxy)ethyl Methacrylate) Hydrogel Dressing for Keloid Therapy
The imiquimod-poly(2-(2-methoxyethoxy)ethyl methacrylate) hydrogel (poly(MEO2MA) hydrogel) dressing was developed for the keloid… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
Isogarcinol Extracted from Garcinia mangostana L. Ameliorates Imiquimod-Induced Psoriasis-like Skin Lesions in Mice.
Isogarcinol (YDIS), a natural compound extracted from Garcinia mangostana L., has a significant immunosuppressive effect on… Expand
Highly Cited
2012
Highly Cited
2012
Blockade of Phosphatidylinositol 3-Kinase (PI3K)δ or PI3Kγ Reduces IL-17 and Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis
Psoriasis is a chronic inflammatory skin disease triggered by interplay between immune mediators from both innate and adaptive… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
2011
2011
A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.
Chlamydia trachomatis (Ct) is the most common sexually transmitted bacterial pathogen in the World and there is an urgent need… Expand
2009
2009
Imiquimod tópico al 5% como alternativa terapéutica en la enfermedad de Paget extramamaria primaria
 
Highly Cited
2008
Highly Cited
2008
Presymptomatic differences in Toll-like receptor function in infants who have allergy.
BACKGROUND Microbial exposure might play a key role in allergy development, but little is known about the role of Toll-like… Expand
2008
2008
FAK-mediated activation of ERK for eosinophil migration: a novel mechanism for infection-induced allergic inflammation.
Bacterial and viral infections often induce the exacerbation of allergic diseases. In this study, we investigated the activation… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2007
Highly Cited
2007
Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils.
Activation of eosinophils by microbe-derived molecules via Toll-like receptors (TLR) potentially provides the link between… Expand
2004
2004
Bowenoid papulosis in a patient with AIDS treated with imiquimod: case report.
A 53-year-old male patient with acquired immunodeficiency syndrome (AIDS) was treated with topical immunomodulator imiquimod for… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE